11:51 AM, 18th Jan 2025
Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 inter alia to consider and approve Un-Audited Financial Results for the Third Quarter and Nine Months ended on 31st December 2024 and to declare Interim Dividend on the equity shares of the Company for the Financial Year 2024-25.